RESEDA, CA - March 19, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new educational resource ...
Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...
Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive disorder produced more energy ...
1don MSN
Weed is actually ‘rarely justified’ to treat anxiety or depression, says major scientific review
A little green might not be a cure for the blues. New research suggests medical marijuana isn’t the mental health miracle ...
A new study suggests that building muscle strength could play a direct role in reducing depression risk, particularly in ...
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results